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graphy appears to be greatest when there is a biphasic response: improvement at low dose and 
worsening at high-dose Dobutamine. The initial improvement in wall motion reflects recruitment o f 
contractile reserve during low-dose Dobutamine, and hence reflects viability. In comparison, higher 
doses lead to subendocardial ischemia and worsening o f  the wall motion abnormality, identifying 
stress-induced ischemia. Thus, testing at various doses appears to be important for the optimal 
assessment o f  myocardial hibernation by this technique. Patients with left ventricular dysfunction 
who demonstrate myocardial viability with Dobutamine stress echocardiography have a better 
survival with revascularization than with medical therapy.
Conclusion: The available data strongly suggests that DSE studies help differentiate viable 
from nonviable myocardium, and identify patients with ischemic LV dysfunction that will most 
likely benefit from coronary revascularization.
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Background: Clubfoot (TEV) is a congenital disorder, involve bone deformity and 
malposition in form o f  a curled shape or twisted position o f  the ankle, heel and toe with soft tissue 
contraction, that if  left untreated can limit a person’s mobility by making it difficult and painful to 
walk although inexpensive and reliable treatment exist, especially with the ponseti method.
Material of study: Congenital clubfoot (CTEV) is including several form o f  deformity: 
Talipes varus, Talipes valgus, Talipes equines, Talipes calcaneus, Talipes cavus. Easily identify in a 
new born which present with abnormal shape and rigid foot, leg torsion and tightening o f  Achilles 
tendon. Therefore immediately apply treatment with gentle manipulation follow by serial o f  casting, 
ending with splintage. Failure o f  conservative treatment and late presentation after 5 month o f  age 
are indications for surgery.
Results: Affected foot is usually smaller and shorter. Approximately appear in 1 case per 
1000 live birth, male-to-female ratio is 2:1, bilateral involvement in 30%-50% o f  cases, there 10% 
chance o f subsequent child being affected if parents already have a child with a clubfoot.
Conclusion: Clubfoot is the most common congenital anomaly o f  the foot found in children, 
frequency ranks second after locomotors pathology. It affects mainly males, as can be unilateral and 
bilateral. Outcome following management is subjectively good for the majority o f  patients.
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Introduction: Hypertension remains a major public health problem associated with 
considerable morbidity and mortality. Hypertensive heart disease is a constellation o f  abnormalities 
that includes left ventricular hypertrophy (LVH), systolic and diastolic dysfunction and their 
clinical manifestations including arrhythmias and symptomatic heart failure (HF). Presently, 
diastolic heart failure accounts for about 50% o f  the heart failure population.
Purpose and objectives: To determine the clinical and laboratory characteristics o f  heart 
failure in patients with hypertension.
Methods: It was a prospective study o f  23 patients admitted in Institute o f  Cardiology
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diagnosed with grade I-III systemic hypertension. We evaluated general date, history o f  disease, 
physical examination, laboratory and instrumental results, including ECG and echocardiography.
Results: In the study group was observed the prevalence o f  women, the rate women: man being
1.9:1, with mean age 59.3 ± 0.02. General data indicated that most patients originate from urban areas -  
19 (82.60%) versus 4(17.40%) from the village. Family history o f  hypertension was present in 2 (9%) 
patients. Among the cardiovascular risk factors were identified type II diabetes in 5(21.7%) and obesity 
in 5(21%) patients. The distribution according stages o f  hypertension demonstrated that most patients 
had stage 1 1 -18  (78.2%), followed by 5 (21.8%) patients -  stage III and only one patient had stage I o f  
hypertension. Clinical spectrum o f  complains showed fatigue in 11, dyspnea -  16, reduced exercise 
tolerance and peripheral edema -  6 patients from study group. By NYHA classification predominated 
the III funcţional class -  14(60, 86%), followed by II class -  6 (26%) and only 3 (13, 04%) patients had 
I NYHA class. ACC/AHA stages o f  HF indicated that most o f  patients were included in stage C -  20 
patients, 2 patients -  stage A and only 1 patient had sage B ofH F . Analyzing ECG was established left 
ventricular hypertrophy in 14 (56.6%). By echocardiography were appreciated concentric hypertrophy 
in 16 (69.6%), cardiomegaly was determined by dilatation o f  left atrium in 19 (82.6%) patients, left 
ventricle -  3(13.04%) and decreased EF <50% in only 4(17.39%) cases.
Conclusion: Patients with hypertension and clinical diagnosis o f  heart failure presented left 
ventricular hypertrophy and impaired diastolic filling without systolic dysfunction.
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Introductoin: Metabolic syndrome is a cluster o f  the most dangerous cardiovascular risk 
factors: diabetes mellitus, abdominal obesity, dyslipidemia and arterial hypertension. According to 
the International Diabetes Federation from 2006, about 25 % o f  the world's population presents the 
metabolic syndrome, with a two-fold higher risk o f  death, and three times more frequently 
myocardial infarction and/or cerebral stroke occurrence.
Purpose o f the study: To assess the influence o f  Nebivolol 5 mg, on carbohydrate and lipid 
metabolism in patients with metabolic syndrome.
Material and methods: The metabolic syndrome diagnosis was established according to the 
criteria proposed in the recommendations o f  the International Diabetes Federation (2005). In our study 
were included 90 patients (divided into two groups: with metabolic syndrome - 45 patients and without 
metabolic syndrome - 45 patients), who received a third generation selective P-blocker with vasodilator 
action -  Nebivolol, 5 mg/day. Indices o f  glucose metabolism, insulin resistance, lipids and apoproteins 
spectrum were evaluated initially and after 2 months o f  treatment with nebivolol.
Results and discussions: Comparative analysis o f  studied indices in patients according to the 
presence o f  metabolic syndrome after treatment with Nebivol, revealed no changes in carbohydrates 
spectrum (basal glycemia, F. Caro index, H bA lc, glycated albumin, glycemic profile) in both 
groups. However, the monotherapy with Nebivolol 5 mg single dose daily for 2 months, was 
associated with significant reduction o f  total cholesterol in patients with metabolic syndrome (p <
0.01) and no reduction o f  it in patients without metabolic syndrome (p>0.05).
Analysis o f  LDL cholesterol has proved essential reduction compared to the initial values in 
the group o f  metabolic syndrome patients (p<0.05) and their slight diminution in the group without 
metabolic syndrome (p>0.05). Similar changes were observed in the dynamics o f  triglycerides by 
important reducing o f  their level in patients with metabolic syndrome (p<0.001) and minor decrease 
in patients without metabolic syndrome (p>0.05). Regarding HDL cholesterol did not change
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